Revvity, Inc. (NYSE: RVTY), announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life ...
(Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ®, announced today that Argonaut will act as the manufacturing partner for Akoya’s IVD assays currently in development. This agreement ...
(NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., a life ...
An explanation of biomagnetic separation process fundamentals A detailed analysis of the five most critical mistakes in biomagnetic separation for IVD-kit manufacturing Crucial advice to help ...
Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element Biosciences, Inc., ...